Skip to main content

Interventions for Injecting Drug Users

  • Chapter
Preventing HIV in Developing Countries

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Musto D. The American Disease: Origins of Narrotic Control. New Haven, CT Yale University Press; 1973.

    Google Scholar 

  2. Mann JM, Tarantola DJM, eds. AIDS in the World II. New York and Oxford: Oxford University Press; 1996.

    Google Scholar 

  3. Des Jarlais DC, Stimson GV, Hagan H, et al. Emerging infectious diseases and the injection of illicit psychoactive drugs. Curr Issues Public Health 1996; 2:102–137.

    Google Scholar 

  4. Des Jarlais DC, Friedman SR. AIDS and IV drug use. Science 1989; 245578–579.

    Google Scholar 

  5. Third Quarterly Report, No 49. World Health Organization-European Commission. Collaborating Centre on AIDS; 1996.

    Google Scholar 

  6. Homberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996; 86(5):642–654.

    Google Scholar 

  7. Des Jarlais DC, Friedman SR, Novick D, et al. HIV-I infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989; 261:1008–1012.

    PubMed  Google Scholar 

  8. Wright N, Vanichseni S, Akarasewi P, et al. Was the 1988 HIV epidemic among Bangkok’s injecting drug users a common source outbreak? AIDS 1994; 8529–532.

    Google Scholar 

  9. Des Jarlais DC, Friedman SR, Choopanya K, et al. International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992; 6:1053–1068.

    PubMed  Google Scholar 

  10. Stimson GV. Recontruction of subregional diffusion of HIV infection among injecting drug users in southeast Asia: Implications for early intervention. AIDS 1994; 8(11):1630–1632.

    PubMed  CAS  Google Scholar 

  11. Zheng X, Tian C, Zhang J, et al. Rapid spread of HIV among drug users and their wives in southwest China. 9th International Conference on AIDS, Berlin, 1993. Abstract No. 2766.

    Google Scholar 

  12. Sarkar S, Das N, Panda S, et al. Rapid spread of HIV among injecting drug user in north-eastern states of India. Bull Narcotics 1994; XLV91–105.

    Google Scholar 

  13. Jacquez J, Koopman J, Simon C, Longini I. Role of the primary infection in epidemic HIV infection of gay cohorts. J Acquir Immunodefic Syndr 1994; 7:1169–1184.

    CAS  Google Scholar 

  14. Ostrow DG. AIDS prevention through effective education. Daedalus 1989; 118:229–254.

    Google Scholar 

  15. Institute for Health Policy Studies. The public health impact of needle exchange programs in the United States and abroad: summary, conclusions and recommendations. School of Public Health, University of California, San Francisco, 1993.

    Google Scholar 

  16. Hartgers C, Buning EC, van Santen GW, et al. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behavior. AIDS 1989; 3:571–576.

    PubMed  CAS  Google Scholar 

  17. Stimson GV. Syringe-exchange programmes for injecting drug users—Editorial review. AIDS 1989; 3:253–260.

    PubMed  CAS  Google Scholar 

  18. Des Jarlais DC, Maynard H. Evaluation of needle exchange program on HIV risk behaviors: Supplemental final report. American Foundation for AIDS Research, New York, 1992.

    Google Scholar 

  19. Dolan KA, Stimson GV, Donoghoe M. Reductions in HIV risk behavior and stable HIV prevalence in syringe-exchange clients and other injectors in England. Drug Alcohol Rev 1993; 12:133–142.

    PubMed  CAS  Google Scholar 

  20. Vlahov D, Astemborski J, Solomon L, Nelson KE. Field effectiveness of needle disinfection among injecting drug users. J Acquir Immunodefic Syndrs 1994; 7:760–766.

    CAS  Google Scholar 

  21. Titus S, Marmor M, Des Jarlais DC, et al. Bleach use and HIV seroconversion among New York City injection drug users. J Acquir Immunodefic Syndr 1994; 7:700–704.

    CAS  Google Scholar 

  22. Gleghorn AA, Doherty MC, Vlahov D, et al. Inadequate bleach contact times during syringe cleaning by injection drug users. J Acquir Immunodefic Syndr 1994; 7:762–772.

    Google Scholar 

  23. Caplehorn JR, Ross MW. Methadone maintenance and the likelihood of risky needle sharing. Int J Addict 1995; 30:685–698.

    PubMed  CAS  Google Scholar 

  24. Neaigus A, Sufian M, Friedman SR, et al. Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ Prevent 1990; 2:253–271.

    CAS  Google Scholar 

  25. Centers for Disease Control. Assessment of street outreach for HIV prevention-selected sites, 1991-1993. MMWR 42(45):873, 879–880.

    Google Scholar 

  26. Abdul-Quader AS, Des Jarlais DC, Tross S, et al. Outreach to injecting drug users and female sexual partners of drug users on the Lower East Side of New York City. Br J Addict 1992; 87: 519–526.

    Google Scholar 

  27. Weibel W, Jimenez A, Johnson W, et al. Positive effect on HIV seroconversion of street outreach intervention with IDU in Chicago: 1988-1992. 9th International Conference on AIDS, Berlin, 1993. Abstract No. WS-C15-2.

    Google Scholar 

  28. Canter ML, Petersen LR, Savage RB, Donagher J. Providing HIV counseling and testing services in methadone maintenance programs. AIDS 1990; 4(5):463–465.

    Google Scholar 

  29. Higgins DL, Galavotti C, O’Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA 1991; 266:2419–2429.

    Article  PubMed  CAS  Google Scholar 

  30. Friedman SR, Des Jarlais DC, Neaigus A, et al. Organizing drug injectors against AIDS: Preliminary data on behavioral outcomes. Psychol Addict Behav 1992; 6:100–106.

    Article  Google Scholar 

  31. Latkin CA, Mandell W, Vlahov D, et al. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: The SAFE study. Am J Commun Psychol 1996; 24:341–364

    CAS  Google Scholar 

  32. Vanichseni S, Sakuntanaga P. Results of three seroprevalence surveys for HIV and IVDU in Bangkok. Sixth International Conference on AIDS, San Francisco, CA, 1990.

    Google Scholar 

  33. Choopanya K, Vanichseni S, Des Jarlais DC, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 1991; 5:1509–1513.

    PubMed  CAS  Google Scholar 

  34. Des Jarlais DC, Choopanya K, Wenston, et al. Risk reduction and stabilization of HIV sero-prevalence among drug injectors in New York City and Bangkok, Thailand. In: Rossi GB, Beth-Giraldo E, Chieco-Bianchi L, et al., (Eds.) Science Challenging AIDS. Basel: Karger, 1992; 207-213

    Google Scholar 

  35. Government of the Socialist Republic of Vietnam. Vietnam National Drug Abuse Control Plan. Hanoi; 1995

    Google Scholar 

  36. Vietnam National AIDS Committee. Annual Report. Hanoi; 1996.

    Google Scholar 

  37. Vietnam National AIDS Committee. Harm Reduction for Injecting Drug Users. Hanoi; 1995.

    Google Scholar 

  38. Quan VM, Chung A, Abdul-Quader AS. Feasibility of a syringe-needle exchange program in Vietnam. Substance Use Misuse 1998; 33(5):1–14.

    Article  Google Scholar 

  39. SHARAN—Annual Report. New Delhi, 1995.

    Google Scholar 

  40. Kumar S, Daniels D. HIV risk reduction strategies among IDUs in Madras: Assessment research report. Madras, India; 1994.

    Google Scholar 

  41. Stimson GV. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. Bull Narcotics 1993; 45(1):3–17.

    CAS  Google Scholar 

  42. Indian Council of Medical Research. Annual Report. Calcutta, 1995.

    Google Scholar 

  43. Kumar S, Daniels D. Empirical evidence of behavior change. Paper presented at the Indo-US Workshop on Behavioral and Social Research on HIV Prevention. Bombay, 1996.

    Google Scholar 

  44. Panda S, Chattejee A, Sarkar S, et al. Injection drug use in Calcutta: A potential focus for an explosive HIV epidemic. Drug Alcohol Rev 1997; 16:17–23.

    PubMed  CAS  Google Scholar 

  45. Hangzo C, Chatterjee A, Sarkar S, et al. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India. Addiction 1997; 92(7):813–820.

    PubMed  CAS  Google Scholar 

  46. Chatterjee A, Hangzo CZ, Abdul-Quader AS, et al. Evidence of effectiveness of street-based peer outreach intervention to change behavior among injecting drug users in Manipur, India. XI International Conference on AIDS, Vancouver, 1996. Abstract No. 4975.

    Google Scholar 

  47. Peak A, Rana S, Mahajan SH, et al. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: The impact of a harm reduction programme. AIDS 1995; 9:1067–1070.

    PubMed  CAS  Google Scholar 

  48. Shreshtha DM, Shreshtha NM, Gautama K. Methadone treatment programme in Nepal: A one-year experience. J Nepal Med Assoc 1995; 33:33–46.

    Google Scholar 

  49. AIDSCAP/Family Health International. Harvard School of Public Health, and UNAIDS. The Status and Trends of the Global HIV/AIDS Pandemic Symposium Final Report. Vancouver, 1996.

    Google Scholar 

  50. Palaniappan N. Intervention among multiracial injecting drug users from different cultural and economical backgrounds. XI International Conference on AIDS, Vancouver, 1996. Abstract No. Mo.D. 1949.

    Google Scholar 

  51. Htoon MT, Lwin HH, San KO, et al. HIV/AIDS in Myanmar. AIDS 1994; 8(suppl 2):S105–S109.

    Google Scholar 

  52. Stimson GV. HIV infection and injecting drug use in the Union of Myanmar: Final report to the United Nations Drug Control Programme, Vienna, Austria, 1994.

    Google Scholar 

  53. Xia M, Kreiss JK, Holmes KK. Risk factors for HIV infection among drug users in Yunnan Province, China: Association with intravenous drug use and protective effect of boiling reusable needles and syringes. AIDS 1994; 8:1701–1706.

    PubMed  CAS  Google Scholar 

  54. Zheng X, Zhang J, Qu X, et al. The sero-prevalence and incidence rates of HIV infection among IDUs by cohort study from 1992 to 1995 in Ruili and other counties of China. XI International Conference on AIDS, Vancouver; 1996. Abstract No. Tu.C. 2515.

    Google Scholar 

  55. Libonatti O, Lima E, Peruga A, et al. Role of drug injection in the spread of HIV in Argentina and Brazil. Int J STD AIDS 1993; 4:135–141.

    PubMed  CAS  Google Scholar 

  56. Fay O, Taborda M, Fernandez A, et al. HIV seroprevalence among different communities in Argentina after four years of surveillance. VII International Conference on AIDS, Florence, Italy; 1991. Abstract No. M.C.3263.

    Google Scholar 

  57. Chequer P, Castilho E, Gomes MRO, et al. Fifteen years of AIDS epidemic in Brazil: Trends over time and perspectives. XI International Conference on AIDS, Vancouver; 1996. Abstract No. Mo.C.1439.

    Google Scholar 

  58. Rangel A, Telles P, Bastos F, et al. HIV risk in 1DUs in Rio de Janeiro: Psychological predictors and implications for intervention. XI International Conference on AIDS, Vancouver; 1996. Abstract No. Tu.C.2495.

    Google Scholar 

  59. de Carvalho HB, Mesquita F, Massad E, et al. HIV and infection of similar transmission patterns in a drug injectors community of Santos, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12(1):84–92.

    PubMed  Google Scholar 

  60. Loures LA, Bittencourt L, Marques F, et al. Dealing with a paradox: The national syringe exchange program in Brazil. XI International Conference on AIDS, Vancouver; 1996. Abstract No. We. C.3562.

    Google Scholar 

  61. Bueno RC, Mesquita F, Haiek R, et al. Bleaching among IDUs in the city of Santos: Results of an intervention by an outreach team. XI International Conference on AIDS, Vancouver; 1996. Abstract No. Pub.C.1259.

    Google Scholar 

  62. Conte M, ďAvila S, Mayer R, et al. The syringe pass. AIDS stay: AIDS prevention program for injection drug users. XI International Conference on AIDS, Vancouver; 1996. Abstract No. We.C.3567.

    Google Scholar 

  63. Stimson GV. The global diffusion of injecting drug use: Implications for HIV infection. VIII International Conference on AIDS, Amsterdam; 1992. Abstract No. 1748.

    Google Scholar 

  64. Brettle RP. HIV and harm reduction for injection drug users. AIDS 1991; 5:125–136.

    PubMed  CAS  Google Scholar 

  65. Des Jarlais DC, Friedman SR, Ward TP. Harm reduction: A public health response to the AIDS epidemic among injecting drug users. Ann Rev Public Health 1993; 14:413–450.

    Google Scholar 

  66. Heather N, Wodak A, Nadelmann E, O’Hare P, eds. Psychoactive Drugs and Harm Reduction: From Faith to Science. Whurr Publishers, London; 1993.

    Google Scholar 

  67. Jacquez J, Koopman J, Simon C, Longini I. Role of the primary infection in epidemic HIV infection of gay cohorts. J Acquir lmmunodefic Syndr 1994; 7:1169–1184.

    CAS  Google Scholar 

  68. Friedman SR, Des Jarlais DC, Ward TP, et al. Drug injectors and heterosexual AIDS. In: L Sherr, ed. AIDS and the Heterosexual Population. Chur, Switzerland: Harwood Academic Publishers; 1994; 41–55.

    Google Scholar 

  69. Ball A, Des Jarlais DC, Donoghoe M, et al. Multi-centre Study on Drug Injecting and Risk of HIV Infection. Geneva: World Health Organization; 1994.

    Google Scholar 

  70. Laumann EO, Gagnon JH, Michael RT, Michaels S. The Social Organization of Sexality: Sexual Practices in the United States. Chicago: University of Chicago Press; 1994.

    Google Scholar 

  71. Vanichseni S, Des Jarlais DC, Choopanya K, et al. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS 1993; 7: 887–891.

    PubMed  CAS  Google Scholar 

  72. Desenclos JC, Papaevangelou G, Ancell-Park R. Knowledge of HIV serostatus and preventive behavior among European injecting drug users. AIDS 1993; 7:1371–1377.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Abdul-Quader, A.S., Des Jarlais, D.C., Chatterjee, A., Hirky, A.E., Friedman, S.R. (2002). Interventions for Injecting Drug Users. In: Gibney, L., Di Clemente, R.J., Vermund, S.H. (eds) Preventing HIV in Developing Countries. AIDS Prevention and Mental Health. Springer, Boston, MA. https://doi.org/10.1007/0-306-47157-4_13

Download citation

  • DOI: https://doi.org/10.1007/0-306-47157-4_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45961-0

  • Online ISBN: 978-0-306-47157-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics